A randomized trial of heparin plus ursodiol vs heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation
- 1 January 2002
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 29 (2) , 137-143
- https://doi.org/10.1038/sj.bmt.1703342
Abstract
Bone Marrow Transplantation is a high quality, peer-reviewed journal covering all aspects of clinical and basic haemopoietic stem cell transplantation.Keywords
This publication has 20 references indexed in Scilit:
- The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantationAmerican Journal of Hematology, 2000
- Ursodiol Prophylaxis against Hepatic Complications of Allogeneic Bone Marrow TransplantationAnnals of Internal Medicine, 1998
- Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institutionBone Marrow Transplantation, 1997
- Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosisGastroenterology, 1996
- LOW MOLECULAR WEIGHT HEPARIN FOR THE PREVENTION OF VENO-OCCLUSIVE DISEASE OF THE LIVER IN BONE MARROW TRANSPLANTATION PATIENTS1Transplantation, 1996
- Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.Journal of Clinical Oncology, 1993
- Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 PatientsAnnals of Internal Medicine, 1993
- Regimen-related toxicity in patients undergoing bone marrow transplantation.Journal of Clinical Oncology, 1988
- VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATIONTransplantation, 1987
- Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing FactorsHepatology, 1984